Ciprofol exerts anti-tumour effects in hepatocellular carcinoma through the Raf-MEK-ERK signalling pathway
Translational Gastroenterology and Hepatology · 2025-07 · 10 · 52-52
DOI: 10.21037/tgh-24-115 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Gastroenterology and Hepatology, 2025-07. Verfasst von Yining Chen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Perioperative Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology and Perioperative Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
- Department of Infectious Disease, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
- Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, NHC Key Laboratory of Living Donor Liver Transplantation (…
- Department of Anesthesiology, the Fourth Affiliated Hospital of Zhejiang University, School of Medicine, Yiwu, China.
- Department of Anesthesiology and Perioperative Medicine, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, China.
- Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
ORCID-Profile: Yining Chen, Xiongxiong Pan
Zitieren
APA
Chen, Y., Shi, P., Zhou, S., Yu, K., Wang, Y., Yao, F., Zhang, R., Liu, X., Fang, C., Tie, X., Li, J., Xu, J., Xu, J., & Pan, X. (2025). Ciprofol exerts anti-tumour effects in hepatocellular carcinoma through the Raf-MEK-ERK signalling pathway. Translational Gastroenterology and Hepatology, 10, 52-52. https://doi.org/10.21037/tgh-24-115
Vancouver
Chen Y, Shi P, Zhou S, Yu K, Wang Y, Yao F, et al. Ciprofol exerts anti-tumour effects in hepatocellular carcinoma through the Raf-MEK-ERK signalling pathway. Translational Gastroenterology and Hepatology. 2025;10:52-52. doi:10.21037/tgh-24-115
BibTeX
@article{Chen2025,
author = {Chen, Yining and Shi, Ping and Zhou, Suiqing and Yu, Kai and Wang, Yulang and Yao, Feifan and Zhang, Ruizhi and Liu, Xinyang and Fang, Chunyao and Tie, Xiaofeng and Li, Jun and Xu, Jing and Xu, Jiali and Pan, Xiongxiong},
title = {Ciprofol exerts anti-tumour effects in hepatocellular carcinoma through the Raf-MEK-ERK signalling pathway},
journal = {Translational Gastroenterology and Hepatology},
year = {2025},
volume = {10},
pages = {52--52},
doi = {10.21037/tgh-24-115}
}
EUVIMED